Shares of Cambridge Cognition Holdings Plc (LON:COG – Get Free Report) crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of GBX 55.09 ($0.69) and traded as low as GBX 51 ($0.64). Cambridge Cognition shares last traded at GBX 51.50 ($0.65), with a volume of 41,185 shares.
Cambridge Cognition Price Performance
The stock has a market cap of £17.98 million, a price-to-earnings ratio of -468.18 and a beta of 0.79. The company has a debt-to-equity ratio of 18.95, a current ratio of 0.45 and a quick ratio of 0.96. The stock’s 50 day simple moving average is GBX 53.83 and its two-hundred day simple moving average is GBX 55.09.
About Cambridge Cognition
Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval, as well as supports sponsors to enhance recruitment, develop safe and effective treatments, and enhance research and development efficiency.
Further Reading
- Five stocks we like better than Cambridge Cognition
- How to Calculate Stock Profit
- The 3 Hottest Insiders Buys This Month
- How to Invest in Insurance Companies: A Guide
- What Bulls and Bears May Be Getting Wrong about SOFI Stock
- Consumer Staples Stocks, Explained
- Microsoft Analysis: Trends, Predictions & Investment Insight
Receive News & Ratings for Cambridge Cognition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cambridge Cognition and related companies with MarketBeat.com's FREE daily email newsletter.